SINTEF Venture III

SINTEF Venture III operates as an early-stage venture capital fund within the broader SINTEF Venture family, managed by SINTEF TTO. It functions as a crucial mechanism for commercializing advanced research and development outcomes generated by the SINTEF Group. The fund specifically targets seed and early-stage opportunities, actively channeling investments into promising spin-off companies that emerge directly from SINTEF’s extensive research portfolio, particularly within sectors such as energy and healthcare.

The larger SINTEF Group, an independent research organization, was established in 1950. Its corporate venture capital arm, SINTEF Venture, formally commenced operations in 2004, driven by the strategic insight to actively translate deep technological expertise into market-ready innovations. SINTEF Venture III represents one iteration in the firm's ongoing commitment to building and nurturing new enterprises from scientific breakthroughs.

The primary beneficiaries of SINTEF Venture III are spin-off ventures and startups leveraging foundational technologies developed at SINTEF. The fund’s overarching vision is to foster the creation of new, high-potential companies that utilize cutting-edge research to address significant challenges and contribute to environmental and social progress. It aims to bridge the gap between academic research and commercial viability.